GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

GETI.B

212.1

0%↓

CAMX

608.5

+2.87%↑

EKTA.B

56.25

-0.35%↓

VITR

132.8

+3.51%↑

AMBEA

141.5

+1.51%↑

Home・Aandelen Lijst・BioArctic AB

B
BioArctic AB

Gesloten

319.6 1.91

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

319

Max

320

Belangrijke statistieken
By Trading Economics
Inkomsten	-208M -29M
Verkoop	-259M 133M
K/W Sectorgemiddelde	28.665 76.798
EPS	-0.98
Winstmarge	-21.576
Werknemers	122
EBITDA	-206M -18M

Marktinformatie
By TradingEconomics
Marktkapitalisatie	2.8B 29B
Vorige openingsprijs	317.69
Vorige sluitingsprijs	319.6

BioArctic AB Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

19 dec 2025, 17:29 UTC

Acquisities, Fusies, Overnames

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- 2nd Update

19 dec 2025, 16:47 UTC

Belangrijke Marktbewegers

Galectin Shares Fall After FDA Raises Issues With Belapectin Program

19 dec 2025, 16:10 UTC

Acquisities, Fusies, Overnames

Union Pacific, Norfolk Southern File for Merger Approval From Surface Transportation Board -- Update

21 dec 2025, 23:51 UTC

Marktinformatie

Oil Rises Amid Growing U.S.-Venezuela Tensions -- Market Talk

21 dec 2025, 23:45 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

21 dec 2025, 23:45 UTC

Marktinformatie

Nikkei May Rise as Yen Weakens -- Market Talk

21 dec 2025, 23:35 UTC

Marktinformatie

Gold Edges Higher Amid Geopolitical Tensions -- Market Talk

19 dec 2025, 22:33 UTC

Winsten

Volkswagen Halts Imports of Its Electric Bus to U.S. Next Year -- WSJ

19 dec 2025, 22:19 UTC

Winsten

FedEx Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

19 dec 2025, 21:48 UTC

Acquisities, Fusies, Overnames

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dec 2025, 21:44 UTC

Winsten

These Stocks Moved the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dec 2025, 21:38 UTC

Winsten

Get Ready for New Chip Shortages. Micron's Success All But Guarantees It. -- Barrons.com

19 dec 2025, 21:00 UTC

Marktinformatie

BEA's Trade-Data Catchup Will Continue Into January -- Market Talk

19 dec 2025, 20:23 UTC

Marktinformatie

Oil Futures End Down Week on Up Note -- Market Talk

19 dec 2025, 20:14 UTC

Marktinformatie

U.S. Natural Gas Futures Post Daily Gain, Weekly Loss -- Market Talk

19 dec 2025, 18:38 UTC

Marktinformatie

U.S. Oil Rig Count Falls By 8 to 406 -- Market Talk

19 dec 2025, 18:00 UTC

Marktinformatie

Winsten

Nike's Margin Outlook Shows Quarter-to-Quarter Improvement -- Market Talk

19 dec 2025, 17:41 UTC

Winsten

These Stocks Are Moving the Most Today: Oracle, Nike, Micron, DJT, Carnival, BioMarin, CoreWeave, Lamb Weston, and More -- Barrons.com

19 dec 2025, 17:24 UTC

Marktinformatie

Winsten

Nike's North America Business is Bright Spot in Turnaround -- Market Talk

19 dec 2025, 17:20 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Tech, Media & Telecom Roundup: Market Talk

19 dec 2025, 17:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

19 dec 2025, 16:29 UTC

Winsten

These Stocks Are Moving the Most Today: Oracle, Nike, FedEx, Micron, DJT, Carnival, BioMarin, Lamb Weston, Winnebago, and More -- Barrons.com

19 dec 2025, 16:20 UTC

Acquisities, Fusies, Overnames

CPKC: Anticipates Submitting Comments to Surface Transportation Board in Accordance With Procedural Schedule

19 dec 2025, 16:19 UTC

Acquisities, Fusies, Overnames

CPKC: Approval of Union Pacific-Norfolk Southern Merger Isn't Inevitable

19 dec 2025, 16:18 UTC

Acquisities, Fusies, Overnames

CPKC: Will Be Thoroughly Reviewing Union Pacific-Norfolk Southern Merger Application Over Coming Days

19 dec 2025, 16:16 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

19 dec 2025, 16:16 UTC

Marktinformatie

U.K. Public Borrowing Data Shows Slow Progress in Reducing Fiscal Deficit -- Market Talk

19 dec 2025, 16:05 UTC

Acquisities, Fusies, Overnames

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dec 2025, 16:04 UTC

Acquisities, Fusies, Overnames

Trump Media Is Making a Big Pivot. Kodak Tried That, Too. -- Barrons.com

19 dec 2025, 15:37 UTC

Marktinformatie

U.S. Labor Market Weakness Could Cause Further Fed Rate Cuts -- Market Talk

Peer Vergelijking

Prijswijziging

BioArctic AB Prognose

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over BioArctic AB

BioArctic AB (publ) develops biological drugs for patients with disorders of the central nervous system in Sweden. The company develops Lecanemab, Lecanemab AHEAD 3-45, and Lecanemab Back-up for the treatment of Alzheimer's disease. In addition, the company develops AD-BT2802 and AD-BT2803 drug projects against Alzheimer's disease that are being combined with blood-brain barrier technology and Brain Transporter to promote uptake of antibodies into the brain. Further, it develops BAN1503, BAN2802, BAN2803, and AD2603 for the treatment of Alzheimer's disease; ND-BT3814, ND3014, andGD-BT6822 for the treatment of neurodegenerative disease; and PD1601, PD-BT2238, and PD1602 for the treatment of Parkinson's disease. It has research collaboration agreement with Eisai and AbbVie. The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016. BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.